Interview-led Coverage

  1. Feb 16, 2026 | Indian Pharma Supplies ~50% Of Prescriptions Dispensed In The U.S. | NileshD Gupta | Vinita Gupta | The Hindu Businessline

  2. Mar 13, 2026 | Lupin Maps Its Future After DBG's Legacy | Business Today

  3. Mar 15, 2026 | Lupin eyes next US growth pillar in complex generics and biosimilars | Business Standard

  4. Mar 16, 2026 | Lupin eyes US growth pill with complex generics, biosimilars | The Indian Express

  5. Mar 18, 2026 | Courage, Crisis, and Creation: The Desh Bandhu Gupta Story | Deccan Chronicle

  6. Mar 25, 2026 | Lupin CEO And MD On Best-In-Class Innovation, Top Spot Ambition And Father’s Legacy | Scrip Citeline

  7. Mar 30, 2026 | Lupin goes for bigger bites of innovation | The Hindu Businessline

  8. Mar 30, 2026 | Lupin goes for bigger bites of innovation - The Hindu BusinessLine | The Hindu Businessline

  9. Apr 17, 2026 | He never dwelled on the past; took bold decisions | Forbes India

  10. Apr 16, 2026 | Manish Sabharwal: How India Built Pharma Industry Against All Odds | CNBC TV18

  11. Apr 24, 2026 | How India Became the Pharmacy of the World in a Constrained Economy | Indian Pharma Outlook

  12. May 4, 2026 | From almost nothing to a global pharma empire: The untold Lupin story | YourStory

  13. May 18, 2026 | BW Dialogue with Manish Sabharwal on Made in India | Business World

  14. May 23, 2026 | A Lupin-spring story | Storyboard18